Company profile
Legacy Technology Holdings, Inc.
OTC: LTHO · Healthcare · Drug Manufacturers - Specialty & Generic
#1166 of 1,422 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 41
v0.1 · 5/100 weight · pillars only
↑ listing tenure, return on assets · ↓ market scale, disclosure history
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$123.0k
Employees
—
as of 2026-08-03
Market cap
$1.7k
as of 2026-08-03
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02020
Net income-$123.0k-$123.0k2020
Operating income-$100.6k-$100.6k2020
Total assets$44.1k$44.1k2020
Liabilities$335.5k$335.5k2020
Equity-$291.5k-$291.5k2020
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Legacy Technology Holdings, Inc.’s revenue?
Legacy Technology Holdings, Inc. booked $0 in FY2020 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
ForU Holdings, Inc.——Dermisonics, Inc.——Isracann Biosciences Inc.——Pure Global Cannabis Inc.——Aamaxan Transport Group, Inc.——Xcorporeal, Inc.——Neighbors
Jefferson →Key facts
CEORedgie T. Green
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersArvada, CO
ExchangeOTC: LTHO
Employees—
IPO date2006-05-16
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.